Insider trades
Sath Shukla, CEO of Spero Therapeutics SPRO, has filed 0 purchases and 11 sales on the open market. The latest trade was on 25/02/05.
Sath Shukla
CEO & President
- Company
- Spero Therapeutics SPRO
- First filing
- 23/02/03
- Trades
- 15 trades
- Buys / sales
- 0 / 11
- 12-month net buying
- No record
- Last trade
- 25/02/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
SPRO | Open-market sale | 25/02/05 | 25/02/05 | 155,333 sh3 trades | $0.78avg. | $121,159.74 | −8.2% |
| Open-market sale | 24/08/27 | 24/08/29 | 2,757 sh | $1.35 | $3,721.95 | −0.2% | |
SPRO | Open-market sale | 24/08/02–24/08/05 | 24/08/06 | 32,441 sh2 trades | $1.31avg. | $42,645.71 | −2.8% |
SPRO | Open-market sale10b5-1 plan | 24/02/02–24/02/05 | 24/02/05 | 75,994 sh2 trades | $1.42avg. | $107,719.22 | −6.1% |
SPRO | Open-market sale10b5-1 plan | 23/08/28–23/08/29 | 23/08/30 | 6,017 sh2 trades | $1.29avg. | $7,747.94 | −1.0% |
| Open-market sale | 23/02/02 | 23/02/03 | 9,504 sh | $1.83 | $17,392.32 | −3.0% |